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Background: LVAD impacts myocardial mechanics; we show the impact on myocardial metabolism regulation by quantification of molecular 
regulators and mediators of energy metabolism.
Methods: Paired samples from Pre and Post-LVAD cardiac tissue were excised from six patients. Three were ischemic, none had diabetes and none 
were taking PPARα or PPARγ agents. The average LVAD time was 135 days. The following RNA transcripts were quantified and compared: GLUT-1 and 
GLUT-2 with standard PCR and PGC-1α, PPARα, PPARγ, NRF-1, UCP-1 and UCP-3 with TaqMan assay.
Results: A significant increase in transcripts for PPARα, PPAR-γ, NRF-1, UCP-1, UCP-3 and GLUT-4. Both PGC-1α and GLUT-1 show a positive trend. 
The increase in the RNA transcript for GLUT-4 suggests improved glucose uptake. The PPARα increment implies increased capacity for β oxidation 
and NRF-1augment indicates mitochondrial biogenesis. Increasing UCP-1 and UCP-3 could serve to alleviate oxidative stress. PPAR-γ’s role on 
myocardial metabolism has not been established.
Conclusions: The LVAD associated increase in glucose transporter transcripts and the increase in PPARα and NRF-1 transcripts are consistent 
with increased mitochondrial number and capacity for oxidative phosphorylation. UCP-1 and UCP-3 elevation indicate decreased oxygen toxicity. In 
sum, the changes suggest improved mitochondrial respiratory and antioxidant capacity.
mRNA/GADH Change P-value
PGC-1α ↔ 0.0795
PPARα ↑ 0.0274
PPARγ ↑ 0.0134
UCP-1 ↑ 0.0092
UCP-3 ↑ 0.0333
NRF-1 ↑ 0.0336
GLUT-1 ↔ 0.094
GLUT-4 ↑ 0.0212
*↑=increase , ↓= decreased, ↔ = no change
